Assessing the effects of antiretroviral therapy-latency-reversing agent combination therapy on eradicating replication-competent HIV provirus in a Jurkat cell culture model
STAR Protocols · 2023
DOI: 10.1016/j.xpro.2023.102547 ↗Kurz gefasst
Fachartikel in der Zeitschrift STAR Protocols, 2023. Verfasst von Kouki Matsuda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima 890-8544, Japan; AIDS Clinical Center, National Center for Glob…. Hauptthemen laut MEDLINE: Proviruses, HIV Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, National Center for Global Health and Medicine, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Eradication of HIV-1 latently infected cells is an important issue in HIV treatment. However, there are limited models available to assess therapeutic efficacy in vitro. Here, we present a protocol for establishing a variety of HIV-infected Jurkat cells, including productive and latent status, evaluating the efficacy of antiviral agents, followed by PCR/sequencing-based detection of replication competent HIV provirus. This protocol is useful for optimization of treatment of HIV-1 and provides insights into the mechanisms of clonal selection of heterogeneous HIV-1-infected cells. For complete details on the use and execution of this protocol, please refer to Matsuda et al. (2021).1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima 890-8544, Japan; AIDS Clinical Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo 162-8655, Japan; Japan Foun…
- Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-8556, Japan.
- AIDS Clinical Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo 162-8655, Japan.
- Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-8556, Japan. Electronic address: y-satou@kumamoto-u.ac.jp.
- Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima 890-8544, Japan. Electronic address: kmaeda@kufm.kagoshima-u.ac.jp.
Förderung
- Japan Agency for Medical Research and Development
- National Center for Global Health and Medicine
- Japan Society for the Promotion of Science
- JST-Mirai Program
Zitieren
APA
Matsuda, K., Tan, B. J. Y., Rajib, S. A., Tsuchiya, K., Satou, Y., & Maeda, K. (2023). Assessing the effects of antiretroviral therapy-latency-reversing agent combination therapy on eradicating replication-competent HIV provirus in a Jurkat cell culture model. STAR Protocols. https://doi.org/10.1016/j.xpro.2023.102547
Vancouver
Matsuda K, Tan BJY, Rajib SA, Tsuchiya K, Satou Y, Maeda K. Assessing the effects of antiretroviral therapy-latency-reversing agent combination therapy on eradicating replication-competent HIV provirus in a Jurkat cell culture model. STAR Protocols. 2023. doi:10.1016/j.xpro.2023.102547
BibTeX
@article{Matsuda2023,
author = {Matsuda, Kouki and Tan, Benjy Jek Yang and Rajib, Samiul Alam and Tsuchiya, Kiyoto and Satou, Yorifumi and Maeda, Kenji},
title = {Assessing the effects of antiretroviral therapy-latency-reversing agent combination therapy on eradicating replication-competent HIV provirus in a Jurkat cell culture model},
journal = {STAR Protocols},
year = {2023},
doi = {10.1016/j.xpro.2023.102547}
}
EUVIMED